title: Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
authors.affiliation: Smith Kline and French Laboratories, Philadelphia, PA, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Wikler
authors.forename: G I
authors.initials: GI
authors.lastname: Moonsammy
authors.forename: D L
authors.initials: DL
authors.lastname: Hemsell
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015296:Ceftizoxime / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D015296:Ceftizoxime; D004318:Doxycycline